A software company bought at a 13x EBITDA multiple can see its first-lien LTV jump from 45% to 73% and its equity value wiped out by 85% if its enterprise value multiple simply re-rates down to 8x. This looming valuation crisis threatens many LBOs financed at the market's peak.

Private equity's reliance on terminal value for returns has created a liquidity crunch for LPs in the current high-rate environment. This has directly spurred demand for fund finance solutions—like NAV lending and GP structured transactions—to generate liquidity and support future fundraising.

In the post-zero-interest-rate era, the “everything rally” driven by liquidity is over. Higher base rates mean companies must demonstrate fundamental strength, not just ride a market wave. This environment rewards active managers who can perform deep credit selection, as weaker credits no longer outperform by default.

A significant, under-the-radar headwind for tech M&A is the instability in the private credit market. Private equity firms, which rely on borrowing to finance large software acquisitions, face higher loan costs and investor uncertainty about the long-term value of software companies. This financial friction is stalling deals that would otherwise happen.

The long-dated nature of biotech investing makes it uniquely vulnerable to high interest rates. A 5% rate applied over a 10-15 year development cycle can compress valuation multiples by three to fourfold, drastically changing the financial landscape for the industry.

Howard Marks highlights a critical issue in private equity: a massive overhang of portfolio companies needing to be sold to return capital. Higher interest rates have made exits difficult, creating a liquidity bottleneck that slows distributions to LPs and commitments to new funds.

The era of generating returns through leverage and multiple expansion is over. Future success in PE will come from driving revenue growth, entering at lower multiples, and adding operational expertise, particularly in the fragmented middle market where these opportunities are more prevalent.

While leverage multiples are similar across the market, Neuberger targets companies acquired at high purchase price multiples (avg. 17x). This strategy results in a significantly lower loan-to-value ratio, providing a larger equity cushion and reducing the lender's ultimate risk.

The standard PE model is broken by its reliance on excessive debt to hit IRR targets and its short 5-7 year hold periods. This combination forces short-term, often detrimental, decisions, creating a paradigm that undermines a company's long-term health and stability.